Hair loss in women: Medical and cosmetic approaches to increase scalp hair fullness

British Journal of Dermatology

Volumn 165, Issue SUPPL. 3, 2011, Pages 12-18

  Sinclair, R ^a   Patel, M ^a   Dawson, T L ^b   Yazdabadi, A ^a   Yip, L ^b   Perez, A ^a   Rufaut, N W ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b P and G Beauty and Grooming   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR ANTAGONIST; ANTIANDROGEN; CYPROTERONE ACETATE; FINASTERIDE; MINOXIDIL; SPIRONOLACTONE; STEROID 5ALPHA REDUCTASE INHIBITOR;

ALOPECIA; FEMALE; HAIR ANALYSIS; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; HAIR TRANSPLANTATION; HUMAN; MALE; MALE TYPE ALOPECIA; NONHUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SCALP HAIR; SEX DIFFERENCE; SHEEP;

5-ALPHA REDUCTASE INHIBITORS; ALOPECIA; ANDROGEN ANTAGONISTS; COSMETIC TECHNIQUES; FEMALE; FINASTERIDE; HAIR; HAIR PREPARATIONS; HUMANS; MINOXIDIL; SCALP DERMATOSES;

EID: 83755220903     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10630.x     Document Type: Review

References (38)

1. Ludwig E,. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977; 97: 247-54. (Pubitemid 8208166)
2. Sinclair R, Jolley D, Mallari R, Magee J,. The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women. J Am Acad Dermatol 2004; 51: 189-99.
3. Olsen EA,. Female pattern hair loss. J Am Acad Dermatol 2001; 45: S70-80. (Pubitemid 32783335)
4. Gan DC, Sinclair RD,. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc 2005; 10: 184-9.
5. Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: a community-based study in six cities. Br J Dermatol 2010; 162: 843-7.
6. Khumalo NP, Jessop S, Gumedze F, Ehrlich R,. Hairdressing and the prevalence of scalp disease in African adults. Br J Dermatol 2007; 157: 981-8. (Pubitemid 47583500)
7. Paik JH, Yoon JB, Sim WY, et al. The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol 2001; 145: 95-9.
8. Cash TF,. The psychology of hair loss and its implications for patient care. Clin Dermatol 2001; 19: 161-6. (Pubitemid 32492958)
9. Biondo S, Sinclair R,. Quality of life in Australian women with female pattern hair loss. Open Dermatol J 2010; 4: 90-4.
10. De Berker DAR, Messenger AG, Sinclair RD,. Disorders of hair. In: Rook's Textbook of Dermatology (, Burns DA, Breathnach SM, Cox NH, Griffiths CEM, eds), 7th edn, Vol. 4. Oxford: Blackwell Publishing, 2004; 63.1-63.120.
11. Sinclair RD, Dawber RP,. Androgenetic alopecia in men and women. Clin Dermatol 2001; 19: 167-78. (Pubitemid 32492959)
12. Messenger AG, Sinclair R,. Follicular miniaturization in female pattern hair loss: clinicopathological correlations. Br J Dermatol 2006; 155: 926-30. (Pubitemid 44564500)
13. Rathnayake D, Sinclair R,. Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. Dermatol Clin 2010; 28: 611-18.
14. Yazdabadi A, Magee J, Harrison S, Sinclair R,. The Ludwig pattern of androgenetic alopecia is due to a hierarchy of androgen sensitivity within follicular units that leads to selective miniaturization and a reduction in the number of terminal hairs per follicular unit. Br J Dermatol 2008; 159: 1300-2.
15. Cousen P, Messenger A,. Female pattern hair loss in complete androgen insensitivity syndrome. Br J Dermatol 2010; 162: 1135-7.
16. Hamilton JB,. Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 1942; 71: 451-80.
17. Schmidt JB, Lindmaier A, Trenz A, et al. Hormone studies in females with androgenic hairloss. Gynecol Obstet Invest 1991; 31: 235-9.
18. Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol 2005; 52: 301-11.
19. Ekmekci TR, Sakiz D, Koslu A,. Occipital involvement in female pattern hair loss: histopathological evidences. J Eur Acad Dermatol Venereol 2010; 24: 299-301.
20. Ekmekci TR, Koslu A,. Phototrichogram findings in women with androgenetic alopecia. Skin Res Technol 2006; 12: 309-12. (Pubitemid 44515681)
21. Price VH,. Androgenetic alopecia in women. J Investig Dermatol Symp Proc 2003; 8: 24-7. (Pubitemid 36900487)
22. Venning VA, Dawber RP,. Patterned androgenic alopecia in women. J Am Acad Dermatol 1988; 18: 1073-7.
23. Blume-Peytavi U, Blumeyer A, Tosti A, et al. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol 2011; 164: 5-15.
24. Riedel-Baima B, Riedel A,. Use of the TrichoScan to assess female pattern hair loss. Dermatol Surg 2009; 35: 651-5.
25. Olsen EA,. The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women. J Am Acad Dermatol 1999; 40: 106-9. (Pubitemid 29051036)
26. Wolverton SE,. Comprehensive Dermatologic Drug Therapy. Philadelphia: Saunders Elsevier, 2007.
27. Brzezinska-Wcislo L,. [Assessment of efficacy of Diane-35 in androgenetic feminine alopecia]. Wiad Lek 2003; 56: 202-5.
28. Dinh QQ, Sinclair R,. Female pattern hair loss: current treatment concepts. Clin Interv Aging 2007; 2: 189-99.
29. Gilmore S, Sinclair R,. Chronic telogen effluvium is due to a reduction in the variance of anagen duration. Australas J Dermatol 2010; 51: 163-7.
30. Stefanato CM,. Histopathology of alopecia: a clinicopathological approach to diagnosis. Histopathology 2010; 56: 24-38.
31. Tosti A, Whiting D, Iorizzo M, et al. The role of scalp dermoscopy in the diagnosis of alopecia areata incognita. J Am Acad Dermatol 2008; 59: 64-7.
32. Messenger AG, Rundegren J,. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004; 150: 186-94. (Pubitemid 38352454)
33. Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol 2004; 50: 541-53. (Pubitemid 38393163)
34. Hoedemaker C, van Egmond S, Sinclair R,. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil. Australas J Dermatol 2007; 48: 43-5. (Pubitemid 46046268)
35. Vexiau P, Chaspoux C, Boudou P, et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol 2002; 146: 992-9. (Pubitemid 34779479)
36. Price VH, Roberts JL, Hordinsky M, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000; 43: 768-76.
37. Unger WP, Unger RH,. Hair transplanting: an important but often forgotten treatment for female pattern hair loss. J Am Acad Dermatol 2003; 49: 853-60. (Pubitemid 37314873)
38. Rogers GE,. Biology of the wool follicle: an excursion into a unique tissue interaction system waiting to be re-discovered. Exp Dermatol 2006; 15: 931-49. (Pubitemid 44688364)